Glucose Intravenous Infusion Bp B. Braun Medical (Glucose Monohydrate)

Glucose Intravenous Infusion Bp B. Braun Medical is employed in several clinical situations where an immediate source of glucose is needed.

• Management of peri‑operative fluid and energy needs.
• Treatment of hypoglycemia when oral glucose is not feasible.
• Provision of calories in patients receiving total parenteral nutrition.
• Support during prolonged fasting or starvation.
• Electrolyte‑balanced carrier for drug dilution in some protocols.

Adverse reactions to glucose intravenous solutions are generally related to the infusion itself and the osmolar load.

Common

• Mild hyperglycemia.
• Local irritation at the infusion site.
• Nausea or vomiting.
• Headache.
• Transient electrolyte shifts, such as mild hyponatremia.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Fluid overload causing pulmonary edema.
• Hyperosmolar hyperglycemic state (HHS) in susceptible patients.
• Allergic or anaphylactic reaction to excipients.

Clinicians should evaluate patient-specific factors before initiating a glucose infusion.

• Assess baseline blood glucose and adjust infusion rate accordingly.
• Monitor fluid balance to avoid overload, especially in cardiac or renal impairment.
• Use caution in patients with diabetes mellitus or insulin resistance.
• Verify compatibility with other intravenous medications before co‑administration.
• Consider electrolyte composition, particularly sodium and potassium levels, to prevent imbalances.
• Avoid rapid infusion in neonates and infants due to risk of hyperglycemia.

Glucose solutions can interact with other intravenous agents or affect the pharmacodynamics of certain drugs.

Avoid

• Co‑infusion with high‑dose insulin without appropriate monitoring.
• Simultaneous administration of drugs that require a low‑glucose environment, such as certain chemotherapeutics.

Use with caution

• Concurrent use of diuretics that may alter fluid status.
• Medications that affect serum potassium (e.g., ACE inhibitors, potassium‑sparing diuretics).
• Vasopressors, as changes in intravascular volume can modify their effect.